微生态失调指数与生物膜免疫原性对牙周治疗预后的预测价值
本研究纳入30例牙周健康对照和30例III期牙周炎患者,计算龈下微生态失调指数(SMDI)和失调比(DR)并量化生物膜免疫原性。结果显示SMDI、DR和免疫原性对牙周炎诊断价值高(AUC>0.90,p<0.001),且SMDI和免疫原性可预测非手术牙周治疗6个月疗效(AUC分别为0.767和0.835,p<0.05)。
要点
- SMDI、DR和生物膜免疫原性对牙周炎诊断的AUC均>0.90(p<0.001)。
- SMDI和生物膜免疫原性可预测NSPT治疗反应,AUC分别为0.767和0.835。
- 达到治疗目标者治疗前SMDI和免疫原性更低(p<0.05)。
核心结论
- 龈下生物膜微生态失调(SMDI)和生物膜免疫原性对牙周炎具有诊断价值,并可预测非手术牙周治疗结局。
研究设计与样本
- 前瞻性研究纳入30例牙周健康对照和30例III期牙周炎患者,病例接受非手术牙周治疗(NSPT),6个月时以≤4个位点探诊深度≥5 mm为治疗达标终点评估疗效。
主要发现
- SMDI、DR和生物膜免疫原性对牙周炎诊断的AUC均>0.90(p<0.001)。
- 牙周炎病例接受NSPT后,三项微生物参数均显著降低(p<0.001)。
- 达到治疗达标终点的病例治疗前SMDI和生物膜免疫原性更低(p<0.05),且再定植模式与疗效差者不同。
- SMDI和生物膜免疫原性预测治疗反应的AUC分别为0.767和0.835(p<0.05)。
关键数值与推荐
- 牙周炎诊断:SMDI、DR和生物膜免疫原性的AUC均>0.90(p<0.001)。
- 治疗达标终点:探诊深度≥5 mm的位点≤4个。
- 治疗反应预测:SMDI的AUC为0.767,生物膜免疫原性的AUC为0.835(p<0.05)。
临床怎么用
- SMDI和生物膜免疫原性可作为牙周炎诊断及NSPT疗效预测的微生物学指标。
- 治疗前SMDI和免疫原性较低者更可能达到治疗达标终点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine the relationship between microbiome dysbiosis indices and biofilm immunogenicity and their prognostic implications on periodontal treatment response. MATERIALS AND METHODS: Thirty periodontally healthy controls and 30 periodontitis cases (stage III) were recruited. Cases received non-surgical periodontal therapy (NSPT), and their treatment response at 6 months was evaluated using a treat-to-target endpoint (≤ 4 sites with probing depths ≥ 5 mm). Pooled subgingival biofilm samples were obtained from controls and cases. The V3-4 hypervariable region of the 16S rRNA gene was sequenced and two compositional indices (subgingival microbiome dysbiosis index, SMDI, and dysbiosis ratio, DR) were calculated. Nuclear factor kappa-B (NF-κB) activation elicited by biofilm samples in monocytic reporter cells was quantified to assess biofilm immunogenicity. RESULTS: SMDI, DR and biofilm immunogenicity were highly diagnostic for periodontitis (area under curves [AUC] > 0.90, p < 0.001). Among periodontitis cases, all three microbial parameters were significantly reduced after NSPT (p < 0.001). Cases achieving the treat-to-target endpoint had lower pre-treatment SMDI and biofilm immunogenicity (p < 0.05) and different microbial recolonization patterns from poor responders. Both measures predicted treatment response (AUC of 0.767 and 0.835, respectively, p < 0.05). CONCLUSION: Subgingival biofilm dysbiosis quantified using SMDI and biofilm immunogenicity was diagnostic of periodontitis and predictive of NSPT outcomes.
引用
- Chew RJJ, Goh CE, Lin XYS, et al. Prognostic Impact of Microbiome Dysbiosis: A Prospective Study. J Clin Periodontol. 2024. PMID: 39439293. doi:10.1111/jcpe.14082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。